The leaders of Japan and China got off to a tense start but have made significant progress in turning around their relations in recent years.Asia Politicsread more
Tech's hottest IPOs of the year, including Beyond Meat and Zoom, dropped on Monday, falling more than the broader market.Technologyread more
Stocks in Asia slipped in Tuesday afternoon trade, while investors looked toward a meeting between U.S. President Donald Trump and Chinese President Xi Jinping set to happen...Asia Marketsread more
A week of dovish fireworks out of the central banking community has just gone by with most of the world's leading central banks now guiding towards easing in light of downside...Commentaryread more
"We do not seek conflict with Iran or any other country," Trump tells reporters in the Oval Office.Politicsread more
Chinese Vice Premier Liu He held a phone conversation with U.S. Trade Representative Robert Lighthizer and U.S. Treasury Secretary Steven Mnuchin, China's Ministry of Commerce...World Economyread more
Sen. Bernie Sanders announced a plan Monday to forgive the country's $1.6 trillion outstanding student loan tab, intensifying the higher education policy debate in the 2020...Personal Financeread more
While earnings usually come in substantially ahead of expectations — as much as 4 or 5 percentage points is not unusual — the downward direction in the outlook doesn't speak...Earningsread more
U.S. President Donald Trump's senior adviser Kellyanne Conway will not testify before the House of Representatives Oversight Committee this week on her alleged violations of...Politicsread more
"We missed being the dominant mobile operating system by a very tiny amount. We were distracted during our antitrust trial. We didn't assign the best people to do the work,"...Technologyread more
PatientsLikeMe was bought by UnitedHealth following a review by Trump's Treasury Department, which scrutinized the start-up because it's backed by Chinese cash.Technologyread more
Cramer advocates speculation but he wouldn't hold this stock for all the tea in China.
The company is Kandi.
"A week ago, I got a call from Stacy in New Jersey, who wanted my opinion on this $651 million China-based firm that makes go carts, all-terrain vehicles and other specialized vehicles."
After extensive research, Cramer learned that Kandi had captured the imaginations of many investors as a bet that it could be the next .
"You see, in 2008, Kandi came out with an inexpensive electric car known as the Coco. Now they're trying to develop a newer model that could be more popular," Cramer explained.
Then, in 2013, Kandi partnered with Geely, a major automaker; the move sparked even greater speculation that they're on the brink of a something big.
"Hey, low cost electric cars plus China, that sounds like a great idea!" said Cramer. As a result shares have surged more than 300% in a year.
Unfortunately, Cramer doesn't think this opportunity is that opportunity. In fact, if you're long, he thinks you should take profits – quickly.
"As far as I can tell, the electric car side of the story is more about hopes and dreams than reality at this point. There's nothing that suggests to me Kandi is anywhere close to becoming next Tesla."
After such sharp gains, that fact alone is enough to send Cramer to the sidelines. But there's more.
The stock has no analyst coverage. "That's right, there's not a single brokerage house covering these guys." That, too, is a red flag for Cramer.
And to make matters even worse, Kandi is facing litigation, from the SEC! That's right, "Kandi is under investigation by the Securities and Exchange Commission, " Cramer said.
Although Kandi has offered no details on the nature of the SEC investigation, which began in November, it should be noted, "As indicated in the subpoena, the investigation is a fact-finding inquiry and does not mean that the company or anyone has broken the law,'' Kandi said in the filing
Nonetheless, an SEC investigation is the last thing Cramer wants to hear when he's holding a stock.
Read MoreMad Money with Jim Cramer
Forthcoming catalyst unnerves Cramer
Sneaker seller off to the races?
Homework: Buy spec vaccine maker?
All told, "this is exactly the kind of company I don't want to own, " Cramer said. "I believe it's a hot stock that ran too much for no real reason. And now there's a serious catalyst looming that could send shares sharply lower."
Therefore, if you've been along for the ride, Cramer says it's time to exit.
"There's only so much risk I'm willing to accept. And at the moment, Kandi has way too much risk for me," Cramer said. "If you have gains ring the register and if you're looking at a new position, looks elsewhere. You can circle back after the SEC issue is resolved but not a moment sooner."
Call Cramer: 1-800-743-CNBC
Questions for Cramer? firstname.lastname@example.org
Questions, comments, suggestions for the "Mad Money" website? email@example.com